StockMarketNewsAlert.com NEW Corporate Stock Alert ~~~~~~~~~~~~~~~~~~~~~~~~~~

Congrats to those that accumulated GOIG, going from $0.001 to $0.06.. 600%! And SSWC from $.0001 to $.0007.. 700%! +++++++++++++++++++++++++++++ Our NEXT company is (Nasdaq:GNBT). Over the next several days GNBT could breakout past its previous highs at $1.14 (We will have more on GNBT shortly) GNBT - http://finance.yahoo.com/qs=gnbt www.generex.com Generex Biotechnology is engaged in the research, development and commercialization of drug delivery systems and technologies.

Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).

The Company`s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company`s proprietary RapidMist(TM) device.

The Company`s flagship product, oral insulin (Generex Oral-lyn(TM)), which has been launched in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world.

Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases.

For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

The Staff StockMarketNewsAlert email:

info@stockmarketnewsalert.com [mailto:info@stockmarketnewsalert.com] web: http://www.stockmarketnewsalert.com ph: 561-807-6350 *Never invest into a stock we discuss unless you can afford to lose your entire investment ~~~~~~~~~~~~~~~~~~~~~~~~~~

DISCLAIMER & RISK DISCLOSURE: First Equity Group Inc Inc (StockMarketNewsAlert and SizzleStocks.com) and our affiliates ("our companies") are not registered investment advisers or broker/dealers. Our companies make no commitment that the purchase of securities of companies profiled or otherwise mentioned in our websites are suitable or advisable for any person or that an investment such securities will be profitable.

FEG compensation for advertising is fifteen thousand cash for sixty days . In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We profile selected companies on our site. Most of these companies provide compensation for profile coverage. Specific questions on membership or profiles can be obtained by writing the Publisher at: info@Stockmarketnewsalert.com [mailto:info@Stockmarketnewsalert.com].

~~~~~~~~~~~~~~~~~~~~~~~~~~